Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Terminated 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 37 Melanoma 17 Prostatic Neoplasms 16 Lung Neoplasms 14 Neoplasms 13 Squamous Cell Carcinoma of Head and Neck 10 Neoplasm Metastasis 9 Carcinoma, Non-Small-Cell Lung 9 Precancerous Conditions 8 Lymphoma 8 Uterine Cervical Neoplasms 6 Pancreatic Neoplasms 6 Leukemia 6 Esophageal Neoplasms 6 Colorectal Neoplasms 6 Colonic Neoplasms 6 Breast Neoplasms, Male 6 Urinary Bladder Neoplasms 5 Rectal Neoplasms 5 Myelodysplastic Syndromes 5 Lymphoma, Follicular 5 Leukemia, Myeloid, Acute 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Head and Neck Neoplasms 5 Barrett Esophagus 5 Adenocarcinoma Of Esophagus 5 Salivary Gland Neoplasms 4 Recurrence 4 Multiple Myeloma 4 Lymphoma, Non-Hodgkin 4

Interventions

Ipilimumab 16 incomplete Freund's adjuvant 9 Nivolumab 9 sargramostim 6 Temozolomide 6 Dacarbazine 6 montanide ISA 51 5 MART-1 Antigen 5 Blood Specimen Collection 5 pembrolizumab 4 Ranibizumab 4 Melphalan 4 Interleukin-2 4 Carboplatin 4 CTLA-4 Antigen 4 Thalidomide 3 Surveys and Questionnaires 3 MAGEA3 protein, human 3 Granulocyte-Macrophage Colony-Stimulating Factor 3 AZD 6244 3 sotrastaurin 2 relatlimab 2 gp100 Melanoma Antigen 2 fludarabine phosphate 2 fludarabine 2 entinostat 2 aflibercept 2 Taxes 2 Sunitinib 2 Sorafenib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Uveal Melanoma × Biopsy × Clear all

NCT00705640 2016-12-16

Mel48

University of Virginia

Phase 1 Completed

Uveal Melanoma, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡